Voltaren injections

Voltaren injections are prescribed for degenerative and inflammatory diseases in the musculoskeletal system. These include arthritis (psoriatic, juvenile chronic, rheumatoid, arthritis in Reiter's disease), Bechterew's disease (ankylosing spondylitis), amyotrophic neuralgia, rheumatism, osteoarthritis.

Voltaren injections are used in the pain syndrome that accompanies sciatica, bursitis, lumbago, tendonitis, neuralgia, ossalgia, arthralgia, myalgia, oncological diseases. The drug is used in the postoperative and post-traumatic state with concomitant inflammation. Voltaren injections are prescribed also for headaches, including migraines.

The indications include algodismenorea, inflammatory conditions in the small pelvis, not excluding adnexitis. During childbirth voltaren injections are used as a tocolytic and analgesic agent.

The medication is used in complex therapy for pathologies of the infectious inflammatory course in the ENT organs, accompanied by severe pain syndrome. Such diseases include pharyngitis, otitis media, tonsillitis. The drug is also used in febrile states.

Voltaren (injection) is contraindicated in hypersensitivity to the drug, as well as other NSAIDs, aspirin asthma and triad (a combination of recurrent polyposis in the paranasal sinuses and nose, bronchial asthma, intolerance of drugs and ASA). The medication is not prescribed for violations in the blood, blood coagulation, erosive-ulcerative gastrointestinal pathology during exacerbation.

Contraindicated drug during pregnancy and lactation.

Following the administration of the drug, the following adverse reactions are possible:

• Spasm or abdominal pain;
• Diarrhea, indigestion, constipation, nausea, gastrointestinal bleeding;
• Jaundice, dry mucous (including the mouth), changes in appetite, cirrhosis, pancreatitis, colitis;
• Headache, sleep disturbance, anxiety, depression, irritability, weakness, convulsions;
• Noise in the ears, violation of taste, visual and auditory perception;
• Itching, alopecia, rash, toxic dermatitis, eczema, photosensitization, exudative erythema multiforme;
• Oliguria, nephrotic syndrome, proteinuria, fluid retention, acute renal failure;
• Thrombocytopenia, anemia, agranulocytosis, leukopenia, eosinophilia;
• Cough, puffiness of the larynx, bronchospasm;
• Increased blood pressure, congestive heart failure;
• Anaphylactic shock, anaphylactoid reactions, edema of the tongue and lips.

Voltaren in ampoules is used intravenously drip. The daily dose should not exceed 150 milligrams. Before administration, the contents of the ampoule are diluted in 100-500 milliliters of a 5% dextrose solution with the addition of sodium bicarbonate.

The duration of the infusion is determined by the degree of severity of the pain syndrome. It can range from thirty to one hundred and eighty minutes.

To prevent postoperative pain, the infusion is performed using a "shock" dose (twenty-five to fifty milligrams for fifteen to sixty minutes). In the future, drip administration is continued at a rate of five milligrams per hour until the maximum allowed daily dose is reached.

In acute conditions or to relieve the aggravation of the chronic form of the disease, a single intramuscular injection is allowed. Further treatment course is carried out by oral administration of the drug, taking into account the maximum allowable dosage - 150 milligrams (including, on the day of injection).

Carrying out long-term therapy presupposes control over liver function, pattern of peripheral blood, analysis of feces for the presence of hidden blood.

During treatment in patients, it is possible to reduce the rate of motor and psychomotor reactions. In this regard, it is recommended to limit activities requiring increased attention.